{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:26:52Z","timestamp":1767626812082},"reference-count":29,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T00:00:00Z","timestamp":1469145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Schizophrenia Association of Great Britain"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.schres.2016.07.020","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T03:37:36Z","timestamp":1469677056000},"page":"186-190","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A study of type-1 diabetes associated autoantibodies in schizophrenia"],"prefix":"10.1016","volume":"176","author":[{"given":"Philomena","family":"Hallford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David St","family":"Clair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Halley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Mustard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2016.07.020_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2012.06638.x","article-title":"Autoimmune diseases and infections as risk factors for schizophrenia","volume":"1262","author":"Benros","year":"2012","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.schres.2016.07.020_bb0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.020_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2012.06.035","article-title":"Maternal antibodies to infectious agents and risk for non-affective psychoses in the offspring\u2014a matched case-control study","volume":"140","author":"Blomstr\u00f6m","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.07.020_bb0020","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","article-title":"Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study","volume":"200","author":"Chen","year":"2012","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.020_bb0025","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00125-005-1879-z","article-title":"Immunological characteristics of diabetes in schizophrenia","volume":"48","author":"Cohen","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.schres.2016.07.020_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148558","article-title":"GAD2 alternative transcripts in the human prefrontal cortex, and in schizophrenia and affective disorders","volume":"11","author":"Davis","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2016.07.020_bb0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.020_bb0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/dme.12099","article-title":"The environment and the origins of islet autoimmunity and type 1 diabetes","volume":"30","author":"Eringsmark Regn\u00e9ll","year":"2013","journal-title":"Diabet. Med."},{"key":"10.1016\/j.schres.2016.07.020_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.schres.2013.07.029","article-title":"A systematic, quantitative review of blood autoantibodies in schizophrenia","volume":"150","author":"Ezeoke","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.07.020_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/dmrr.232","article-title":"Prevalence and fate of type 1 diabetes-associated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers","volume":"18","author":"H\u00e4m\u00e4l\u00e4inen","year":"2002","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.schres.2016.07.020_bb0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nature08185","article-title":"Common polygenic variation contributes to risk of schizophrenia and bipolar disorder","volume":"460","author":"International Schizophrenia Consortium, Purcell","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.schres.2016.07.020_bb0060","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archpsyc.64.8.894","article-title":"Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus","volume":"64","author":"Juvonen","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.020_bb0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1176\/appi.ajp.2012.11081197","article-title":"Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring","volume":"169","author":"Karlsson","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.020_bb0070","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1056\/NEJMoa1004809","article-title":"Dietary intervention in infancy and later signs of beta-cell autoimmunity","volume":"363","author":"Knip","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.schres.2016.07.020_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002270","article-title":"Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms","volume":"3","author":"Monsuur","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2016.07.020_bb0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/oby.2008.484","article-title":"Regulation of pituitary gene expression by adrenalectomy","volume":"17","author":"Nishida","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.schres.2016.07.020_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.schres.2016.07.020_bb0090","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia associated genetic loci","volume":"511","author":"Schizophrenia Working Group Of The Psychiatric Genomics Consortium","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.schres.2016.07.020_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature16549","article-title":"Schizophrenia risk from complex variation of complement component 4","volume":"530","author":"Sekar","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.schres.2016.07.020_bb0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1373\/clinchem.2010.148221","article-title":"Genetics of type 1 diabetes","volume":"57","author":"Steck","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.schres.2016.07.020_bb0105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/sj.mp.4001988","article-title":"Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression","volume":"12","author":"Straub","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2016.07.020_bb0110","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","article-title":"Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies","volume":"60","author":"Sullivan","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2016.07.020_bb0115","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1745-7580-6-S2-S7","article-title":"Concept and application of a computational vaccinology workflow","volume":"6","author":"S\u00f6llner","year":"2010","journal-title":"Immunome. Res."},{"key":"10.1016\/j.schres.2016.07.020_bb0120","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2014.10.011","article-title":"GABA abnormalities in schizophrenia: a methodological review of in vivo studies","volume":"167","author":"TAYLOR","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.07.020_bb0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2010.04.001","article-title":"Etiology of type 1 diabetes","volume":"32","author":"Todd","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.schres.2016.07.020_bb0130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/1471-2105-11-568","article-title":"Peptide binding predictions for HLA DR, DP and DQ molecules","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.schres.2016.07.020_bb0135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.jcp.0000095349.32154.a5","article-title":"GABA and schizophrenia: a review of basic science and clinical studies","volume":"23","author":"Wassef","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2016.07.020_bb0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0920-9964(96)82950-1","article-title":"Autoimmune diseases in the pedigrees of schizophrenic and control subjects","volume":"20","author":"Wright","year":"1996","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.schres.2016.07.020_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.schres.2008.06.019","article-title":"Glutamic acid decarboxylase (GAD) antibodies in tardive dyskinesia (TD) as compared to patients with schizophrenia without TD and normal controls","volume":"105","author":"Yarlagadda","year":"2008","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416303462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416303462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T20:40:43Z","timestamp":1568234443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416303462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":29,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0920996416303462"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.07.020","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of type-1 diabetes associated autoantibodies in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}